Keyphrases
4-galactosyltransferase
16%
Aged Mice
25%
Asialo-rhuEPO
37%
Asialoerythropoietin
62%
Biotechnology Industry
12%
Brain Injury
12%
Clinical Practice
12%
Clinical Translation
12%
Clinical Trials
12%
Co-expression
12%
Complex N-glycans
33%
Cytotoxic Agents
24%
Desialylation
12%
Effect Mechanism
12%
Erythropoietin
29%
Erythropoietin Derivatives
16%
Expression Level
12%
Expression System
12%
HL-1 Cardiomyocytes
16%
Human Erythropoietin
16%
Hypothesis-driven Research
16%
Hypoxia
24%
Induced Cell Death
12%
Ischemia-reperfusion Injury
50%
Kidney
12%
Laboratory Experiences
12%
Liver
12%
Long-term Neurological Outcome
18%
Mammalian Cells
12%
Mechanism of Action
37%
Middle Cerebral
12%
Mouse Model
24%
Mouse Neuroblastoma Cells
16%
Neuroprotective
37%
Neuroprotective Action
37%
Neuroprotective Drugs
12%
Neuroprotective Effect
12%
Neuroprotective Mechanisms
12%
Neuroprotective Properties
41%
Nonhematopoietic
16%
Pharmaceutical Biotechnology
12%
Pharmacological Attributes
12%
Pharmacological Studies
37%
Plant-based Expression System
29%
Plant-produced
62%
Protective Behavior
12%
Protective Effect
37%
RhEPO
12%
Science Laboratory
12%
Scientific Competencies
16%
Sialic Acid
24%
Solid Foundation
12%
Staurosporine
16%
Stroke Patients
12%
Stroke Treatment
12%
Tissue Injury
12%
Tobacco Leaf
16%
Tobacco Plants
12%
Training Opportunities
12%
Transgenic Tobacco
16%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
12%
Cytoprotective Agent
12%
Cytotoxic Agent
24%
Erythropoietin
87%
Galactosyltransferase
16%
Glycan
25%
Hypoxia
24%
Injury
11%
Ischemia
24%
Mouse
36%
Mouse Model
24%
Murine
12%
Neuroblastoma
12%
Neuroprotective Agent
87%
Pharmaceutical Biotechnology
16%
Recombinant Erythropoietin
16%
Reperfusion Injury
24%
Sialic Acid
24%
Staurosporine
16%
Tissue Injury
12%
Immunology and Microbiology
Cardiac Muscle Cell
12%
Cell Damage
6%
Cell Death
18%
Epoetin Beta
16%
Erythropoietin
100%
Gene Expression System
50%
Glycan
25%
Middle Cerebral Artery
6%
Mouse
62%
Mouse Model
37%
Murine
12%
Neuroblastoma Cell
12%
Reperfusion
75%
Transgenics
12%